Hydrochloric Acid

Hydrochloric Acid

SCHEMBL865599

CCN(CC)c1ccc2nc3cc(C)c(N)cc3[n+](-c3ccccc3)c2c1.[Cl-]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.36
NPC1 O15118 3/20 0.74
RAB9A P51151 3/20 0.74
NLRP3 Q96P20 2/20 0.74
L3MBTL1 Q9Y468 2/20 0.74
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
USP2 O75604 1/20 0.50
POLB P06746 1/20 0.50
BLM P54132 1/20 0.50
S100B P04271 1/20 0.46
APAF1 O14727 1/20 0.41
TERT O14746 1/20 0.40
MAPT P10636 6/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HTT P42858 2/20 0.36
GAA P10253 2/20 0.36
MAPK1 P28482 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19970692 1.00 NPC1 (0.74) NPC1RAB9ANLRP3L3MBTL1MEN1
Hydrochloric Acid SCHEMBL29536468 0.88 NPC1 (0.85) NPC1RAB9ANLRP3L3MBTL1MEN1
SCHEMBL19970699 0.88 NPC1 (0.85) NPC1RAB9ANLRP3L3MBTL1MEN1
Hydrochloric Acid SCHEMBL866737 0.87 APAF1 (0.57) NPC1RAB9ANLRP3L3MBTL1MEN1
SCHEMBL20555119 0.87 APAF1 (0.57) NPC1RAB9ANLRP3L3MBTL1MEN1
Hydrochloric Acid SCHEMBL930666 0.85 L3MBTL1 (1.00) NPC1RAB9ANLRP3L3MBTL1MEN1
SCHEMBL3130463 0.85 L3MBTL1 (1.00) NPC1RAB9ANLRP3L3MBTL1MEN1
Hydrochloric Acid SCHEMBL28418789 0.84 NPC1 (0.79) NPC1RAB9ANLRP3L3MBTL1MEN1
Butane SCHEMBL931598 0.84 NPC1 (0.49) NPC1RAB9ANLRP3L3MBTL1MEN1
SCHEMBL31680480 0.83 NPC1 (0.47) NPC1RAB9ANLRP3L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619244-B1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN INC (US) 2018-11-14 EP claimed
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds MACDERMID ACUMEN, INC. (US) 2014-06-12 US claimed
US-8735580-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2014-05-27 US claimed
EP-2619244-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MacDermid Acumen, Inc. (US) 2013-07-31 EP claimed
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US claimed
WO-2012040417-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN, INC. (US) 2012-03-29 WO claimed
US-20120077956-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US claimed
EP-2619244-B1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN INC (US) 2018-11-14 EP disclosed
US-9040700-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2015-05-26 US disclosed
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds MACDERMID ACUMEN, INC. (US) 2014-06-12 US disclosed
US-8735580-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2014-05-27 US disclosed
EP-2619244-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MacDermid Acumen, Inc. (US) 2013-07-31 EP disclosed
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US disclosed
WO-2012040417-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN, INC. (US) 2012-03-29 WO disclosed
US-20120077956-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US disclosed
US-4118384-A DIAZOTIZATION BAYER AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds NOX5, PRMT5, CHRM5 ACHE 396/4885NPC1 4874/4885RAB9A 1380/4885
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds NOX5, PRMT5, H1-5 ACHE 590/4885NPC1 4882/4885RAB9A 1573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.